World News: 21:01 GMT Tuesday 30th July 2019. [Fate Therapeutics, Inc. via Globe Newswire via SPi World News]
SAN DIEGO July 30 2019 GLOBE NEWSWIRE -- Fate Therapeutics Inc NASDAQ FATE a clinical-stage biopharmaceuticaldedicated to the development of programmed cellular immunotherapies for and immune disorders today th at the ...
Globe Newswire: 21:01 GMT Tuesday 30th July 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.